Trial
NCT00763035
Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
Astellas Pharma US, Inc.
Condition
Coronary Artery Disease
Intervention
Regadenoson
Why stopped
Potential participants with COPD/asthma unwilling to participate.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-26